Streetbeat News

Products Services

LGHL

Lion Group Holding Ltd. (NASDAQ:LGHL) has announced the launch of its intelligent trading algorithm service 'Phoenix', which is based on AI technology. The service is expected to enhance the core competitiveness of the company's products and become a new driver of Lion's performance growth. The 'Phoenix' system integrates intelligent trading, strategy customization, and margin trading and short selling, and is designed to improve the quality of investment decisions and investment results.

Portfolio Pulse from Happy Mohamed

September 05, 2023 | 1:03 pm

VTGN

Vistagen and Fuji have entered into an exclusive negotiation agreement for a potential license to develop and commercialize Vistagen's investigational menopausal hot flash therapy, PH80 Nasal Spray, in Japan. Vistagen will receive $1.5 million and Fuji will obtain a time-limited exclusive negotiation period for the Japanese market. A recent Phase 2A study showed PH80's significant reduction in the number of hot flashes and related symptoms compared with placebo.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2023 | 1:03 pm

DD

DuPont Interconnect Solutions has entered into a strategic collaboration with YMT, a Korean printed circuit board materials manufacturer. The collaboration aims to enhance the distribution and service of Riston dry film photoresist in Korea. YMT has invested in a dry film slitting facility in Ansan, Korea, which is expected to be operational in October. The partnership will leverage DuPont's circuit imaging material expertise and YMT's local network to better serve local customers.

Portfolio Pulse from Happy Mohamed

September 05, 2023 | 1:03 pm

ZM

Zoom is set to expand its generative AI offering with the launch of AI Companion, which will be available at no additional cost with paid Zoom user accounts. The company's federative approach to AI incorporates its own large language models and third-party models such as Meta Llama 2, OpenAI, and Anthropic.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2023 | 1:01 pm

BMWYY

MBGYY

QCOM

Qualcomm Inc has announced partnerships with BMW and Mercedes Benz to provide enhanced multimedia and in-car infotainment systems. The Snapdragon Digital Chassis Solutions will be used in the 2024 Mercedes-Benz E-Class Sedan. BMW will use the Snapdragon Cockpit Platform and Snapdragon Auto Connectivity Platforms for 5G connectivity in their new in-vehicle experiences. The companies are also co-developing a comprehensive ADAS system based on the Snapdragon Ride Platform.

Portfolio Pulse from Shivani Kumaresan

September 05, 2023 | 12:53 pm

BCDA

BioCardia Inc's stock is plunging after the company released interim efficacy results for its phase 3 pivotal CardiAMP cell therapy heart failure trial. The results showed that the 250-patient randomized controlled study is unlikely to meet its primary three-tiered Finkelstein-Schoenfeld (FS) efficacy endpoint. The company's shares are down 23% at $0.60 during the premarket session.

Portfolio Pulse from Vandana Singh

September 05, 2023 | 12:50 pm

ABNB

HSDT

VERB

VERB Technology Company, Inc. has launched a groundbreaking TikTok integration on its MARKET.live platform. Helius Medical Technologies, Inc. is now compliant with all applicable Nasdaq listing criteria. Airbnb's shares are trading higher after the announcement of its inclusion in the S&P 500.

Portfolio Pulse from ryanfaloona@benzinga.com

September 05, 2023 | 12:45 pm

ARCT

CSL

Arcturus Therapeutics (NASDAQ:ARCT) and CSL (ASX:CSL) announced that the European Medicines Agency (EMA) has validated the marketing authorization application for ARCT-154, a next-generation mRNA vaccine for COVID-19. The EMA submission is based on successful Phase 3 clinical results, with an approval decision expected by the European Commission in 2024. ARCT-154 showed 56.6% efficacy for prevention of symptomatic COVID-19 and 95.3% efficacy for prevention of severe COVID-19.

Portfolio Pulse from Happy Mohamed

September 05, 2023 | 12:45 pm

NVO

SLGC

SomaLogic has extended its collaborative agreement with Novo Nordisk until the end of 2025. As part of the agreement, Novo Nordisk will expand its use of the SomaScan proteomics platform in drug research and development, and will also use SomaLogic's SomaSignal tests for investigations into cardiometabolic and other diseases.

Portfolio Pulse from Happy Mohamed

September 05, 2023 | 12:43 pm

TNXP

Tonix Pharmaceuticals announced topline results from the Phase 2 proof-of-concept PREVAIL study of TNX-102 SL 5.6 mg for managing fibromyalgia-type Long COVID, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2023 | 12:38 pm